SIC 2835 – In Vitro and In Vivo Diagnostic Substances
Valuation | |
---|---|
Market Cap ($M) | 2,691.61 |
Enterprise Value ($M) | 5,098.31 |
Book Value ($M) | 3,186.70 |
Book Value / Share | 47.38 |
Price / Book | 0.84 |
NCAV ($M) | -2,201.80 |
NCAV / Share | -32.74 |
Price / NCAV | -1.22 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.31 |
Return on Assets (ROA) | -0.22 |
Return on Equity (ROE) | -0.38 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.81 |
Current Ratio | 1.38 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 1,412.60 |
Assets | 6,801.10 |
Liabilities | 3,614.40 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | T. Rowe Price Investment Management, Inc. | 14.00 | 8.05 | |
13G | Rubric Capital Management LP | 6.25 | ||
13G/A | Vanguard Group Inc | 9.00 | 0.00 | |
13G/A | BlackRock, Inc. | 10.80 | ||
13D/A | Carlyle Group Inc. | 13.00 | -7.62 | |
13G/A | BlackRock Inc. | 7.20 | -4.39 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
121,137 | 711,766 | 17.02 | |
96,069 | 526,750 | 18.24 | |
173,142 | 598,856 | 28.91 | |
211,726 | 1,355,197 | 15.62 | |
(click for more detail) |
Similar Companies | |
---|---|
PRTA – Prothena Corporation plc | PTCT – PTC Therapeutics, Inc. |
PYXS – Pyxis Oncology, Inc. | QNCX – Quince Therapeutics, Inc. |
QURE – uniQure N.V. |
Financial data and stock pages provided by
Fintel.io